Cargando…
Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An in vitro and in vivo study
Colorectal cancer is a major health problem, and it is the third most diagnosed cancer in the United States. The current treatment for colorectal cancer includes irinotecan, a topoisomerase I inhibitor, and other targeted drugs, such as bevacizumab and regorafenib. The low response rates and inciden...
Autores principales: | Narayanan, Silpa, Teng, Qiu-Xu, Wu, Zhuo-Xun, Nazim, Urooj, Karadkhelkar, Nishant, Acharekar, Nikita, Yoganathan, Sabesan, Mansoor, Najia, Ping, Feng-Feng, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386487/ https://www.ncbi.nlm.nih.gov/pubmed/35992866 http://dx.doi.org/10.3389/fonc.2022.949868 |
Ejemplares similares
-
Synthesis and in Vitro Evaluation of New Nitro-Substituted Thiazolyl Hydrazone Derivatives as Anticandidal and Anticancer Agents
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2014) -
The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug Resistance
por: Narayanan, Silpa, et al.
Publicado: (2021) -
Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer
por: Yoganathan, Sabesan, et al.
Publicado: (2021) -
Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates
por: Gupta, Pranav, et al.
Publicado: (2019) -
MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: In vitro and in vivo study
por: Wu, Zhuo-Xun, et al.
Publicado: (2022)